EU-X-CT - TF3 Mapping: The EU Cross-border Clinical Trials Multi-Stakeholders Initiative (PATIENT)
Language
  • English (UK)
  • Español
  • Français
  • Dansk
  • Deutsch
  • Nederlands
  • Czech
  • Slovak
  • Croatian
  • Greek
  • Magyar
  • Polski
  • Macedonian
  • Română
  • Bulgarian
  • Norsk
  • Portuguese (Portugal)
  • Estonian
  • Latvian
  • Slovenian
  • Finnish
  • Svenska
  • Italiano
  • Serbian
  • Türkçe
  • Georgian

  •          SELECT YOUR LANGUAGE                                                                        

                                                                                                                         

  • The EU Cross-border Clinical Trials Multi-Stakeholders Initiative

    Borders should no longer be barriers

  • Questions to PATIENTS and CAREGIVERS

    Operational questions

  • EU-X-CT (“EU Cross-border clinical trials”) is a project that is trying to simplify the process for a possible participant from one country to take part in a clinical trial in another country.  

    The project includes doctors, patients and their representatives, hospitals, pharmaceutical companies, universities, insurance companies and others.

    To help us find ways to overcome the current challenges, please describe your current experience including both what went well, and what was a challenge. If you need more space to describe your particular situation, use the open space at the end. We are also very keen on learning about your preferences, even if you have not participated in a clinical trial before.  

    Please be aware that you can save a draft of your answers, but it will only save on your computer/browser so if you are using a different browser or computer, you will have to start from the beginning.

  • Which disease were you diagnosed with? (more than one option possible)*
  • I am happy to share my diagnosis with you*
  • Do you know about clinical trials in your country of residence?*
  • Where do you find information about clinical trials in your country of residence (multiple answers)?*
  • If a clinical trial was an option for you, would you consider taking part?*
  • Do you know about clinical trials for people living with the same disease as you outside of your country of residence?*
  • If a clinical trial was an option for you, have you ever considered taking part in one outside of your country of residence or would you consider to participate if you were aware of such a clinical trial?*
  • When was the last time you participated in a clinical trial outside of your country of residence?*
  • How did you find out about the clinical trial that you participated in (or wanted to participate in) - multiple answers?*
  • Do you know which phase of clinical trial you participated in?*
  • Which phase was it?*
  • How easy was it to organize taking part in the clinical trial ? *
  • Have you experienced language and/or cultural challenges when trying to access a clinical trial outside of your country of residence? *
  • What were those challenges?*
  • Have you experienced challenges with accommodation close to the trial site?*
  • What were those challenges?*
  • Have you experienced challenges with travel arrangements for you and/or person accompanying you to the trial site?*
  • What were those challenges?*
  • Have you experienced challenges with sharing of medical records with the trial sites outside your country of residence?*
  • What were those challenges?*
  • Have you experienced challenges with getting the trial medication when you returned to your country of residence?*
  • What were those challenges?*
  • Have you experienced the use of Telemedicine to support you in a clinical trial?*
  • What form of Telemedecine have you experienced?*
  • Have you experienced challenges with continuation of your medical care after returning to your country of residence?*
  • What were those challenges?*
  • What were other additional major challenges for you (multiple choices)?*
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • What category does the investigational medicinal product in the clinical study fall under?*

  • Terms of Use and Data Protection Policy

  • The answers to this questionnaire are anonymous.

    By filling out this survey, you:

    • agree and consent that the information provided in this questionnaire can be used for the purpose of EU-X-CT mapping exercise and published
    • agree and consent for the data to be stored by EFGCP (data controller) and made accessible to the EU-X-CT Members for the purpose mentioned above

    The legal basis for processing your personal data is consent (Article 6(1)(a) of Regulation (EU) 2016/679).

    If you have additional questions on the data privacy policy, you can contact the EFGCP Data Protection Officer of the EFGCP in writing at secretariat@efgcp.eu

  • Would you agree to be contacted for follow-ups?

    By submitting this questionnaire, you will be moved to another form in which you can provide us with your contact information should you wish to do so.

    This second form will not be linked with this survey, all data provided within this survey will remain anonymous.

  • Thank you for your time and completing this survey. Your contribution is valuable and much appreciated, it will help us to improve our understanding of cross-border access to clinical trials for patients.

    If you have any questions or require additional information, please contact the EU-X-CT Secretariat at eu-x-ct@efgcp.eu

    Yours sincerely

     EU-X-CT Team

  • Should be Empty: